IRO-203: a novel intranasal COVID-19 vaccine showing immunogenicity and viral suppression in African green monkey challenge study
Findings highlight the ability of IRO‑203 to induce measurable immune responses and to partially reduce viral RNA levels in a non-human primate challenge model and suggest that the nT-SeV vector represents an attractive platform for developing vaccines against other respiratory infectious diseases.